A switch of GPCR binding preference from PI3K-p85 to filamin-A negatively controls the PI3K pathway.
Najib S, Saint-Laurent N, Estève JP, Schulz S, Boutet-Robinet E, Fourmy D, Lättig J, Mollereau C, Pyronnet S, Susini C,
Bousquet C. Mol Cell Biol. 2011 Dec 27. PMID : 22203038.
Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.
Mavigner M, Cazabat M, Dubois M, L’faqihi FE, Requena M, Pasquier C, Klopp P, Amar J,
Alric L, Barange K, Vinel JP, Marchou B, Massip P, Izopet J, Delobel P. J Clin Invest. 2011 Dec 12. pii : 59011. doi : 10.1172/JCI59011. PMID : 22156200
Prognostic Impact of Morphologic and Phenotypic Features of Childhood ALK-Positive Anaplastic Large-Cell Lymphoma : Results of the ALCL99 Study.
Lamant L, McCarthy K, d’Amore E, Klapper W, Nakagawa A, Fraga M, Maldyk J, Simonitsch-Klupp I, Oschlies I,
Delsol G, Mauguen A, Brugières L, Le Deley MC. J Clin Oncol. 2011 Dec 10 ;29(35):4669-76.
A phase 3 trial of bevacizumab in ovarian cancer.
Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Kurzeder C, du Bois A, Sehouli J, Kimmig R, Stähle A, Collinson F, Essapen S, Gourley C, Lortholary A, Selle F, Mirza MR, Leminen A, Plante M, Stark D, Qian W, Parmar MK, Oza AM ; ICON7 Investigators.
N Engl J Med. 2011 Dec 29 ;365(26):2484-96.
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2) : a randomised, placebo-controlled, phase 3 study.
Pavel ME, Hainsworth JD, Baudin E, Peeters M, Hörsch D, Winkler RE, Klimovsky J, Lebwohl D, Jehl V, Wolin EM, Oberg K, Van Cutsem E, Yao JC ; RADIANT-2 Study Group.
Lancet. 2011 Dec 10 ;378(9808):2005-12.
p27(Kip1) represses transcription by direct interaction with p130/E2F4 at the promoters of target genes.
Pippa R, Espinosa L, Gundem G, García-Escudero R, Dominguez A, Orlando S, Gallastegui E, Saiz C,
Besson A, Pujol MJ, López-Bigas N, Paramio JM, Bigas A, Bachs O. Oncogene. 2011 Dec 19. doi : 10.1038/onc.2011.582. PMID : 22179826
Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasis.
Malek JA, Mery E, Mahmoud YA, Al-Azwani EK, Roger L, Huang R, Jouve E, Lis R, Thiery JP,
Querleu D, Rafii A. PLoS One. 2011 ;6(12):e28561. Epub 2011 Dec 14. PMID : 22194851
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.
Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Greene MH, Mai PL, Andrulis IL ; Ontario Cancer Genetics Network, Thomassen M, Gerdes AM, Caligo MA, Friedman E, Laitman Y, Kaufman B, Paluch SS, Borg Å, Karlsson P, Askmalm MS, Bustinza GB ; SWE-BRCA Collaborators, Nathanson KL, Domchek SM, Rebbeck TR, Benítez J, Hamann U, Rookus MA, van den Ouweland AM, Ausems MG, Aalfs CM, van Asperen CJ, Devilee P, Gille HJ ; HEBON ; EMBRACE, Peock S, Frost D, Evans DG, Eeles R, Izatt L, Adlard J, Paterson J, Eason J, Godwin AK, Remon MA, Moncoutier V, Gauthier-Villars M, Lasset C, Giraud S, Hardouin A, Berthet P, Sobol H, Eisinger F, Bressac de Paillerets B, Caron O, Delnatte C ; GEMO Study Collaborators, Goldgar D, Miron A, Ozcelik H, Buys S, Southey MC, Terry MB ; Breast Cancer Family Registry, Singer CF, Dressler AC, Tea MK, Hansen TV, Johannsson O, Piedmonte M, Rodriguez GC, Basil JB, Blank S, Toland AE, Montagna M, Isaacs C, Blanco I, Gayther SA, Moysich KB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Sutter C, Gadzicki D, Fiebig B, Caldes T, Laframboise R, Nevanlinna H, Chen X, Beesley J, Spurdle AB, Neuhausen SL, Ding YC, Couch FJ, Wang X, Peterlongo P, Manoukian S, Bernard L, Radice P, Easton DF, Chenevix-Trench G, Antoniou AC, Stoppa-Lyonnet D, Mazoyer S, Sinilnikova OM ; Consortium of Investigators of Modifiers of BRCA1/2.
Hum Mol Genet. 2011 Dec 1 ;20(23):4732-47.
Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas.
Dejean E, Renalier MH, Foisseau M, Agirre X, Joseph N, de Paiva GR, Al Saati T, Soulier J, Desjobert C, Lamant L, Prósper F, Felsher DW, Cavaillé J, Prats H, Delsol G, Giuriato S, Meggetto F.
Leukemia. 2011 Dec ;25(12):1882-90. doi : 10.1038/leu.2011.168. Epub 2011 Jul 22. PMID : 21778999
High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia : a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.
Vergez F, Green AS, Tamburini J, Sarry JE, Gaillard B, Cornillet-Lefebvre P, Pannetier M, Neyret A, Chapuis N, Ifrah N, Dreyfus F, Manenti S, Demur C,
Delabesse E, Lacombe C, Mayeux P, Bouscary D, Recher C, Bardet V. Haematologica. 2011 Dec ;96(12):1792-8.
Semisynthetic neoboutomellerone derivatives as ubiquitin-proteasome pathway inhibitors.
Beck J, Guminski Y, Long C, Marcourt L, Derguini F, Plisson F, Grondin A, Vandenberghe I, Vispé S, Brel V, Aussagues Y, Ausseil F, Arimondo PB, Massiot G, Sautel F, Cantagrel F.
Bioorg Med Chem. 2011 Dec 8. PMID : 22206869
Proteasome Inhibitors from Neoboutonia melleri.
Long C, Beck J, Cantagrel F, Marcourt L, Vendier L, David B, Plisson F, Derguini F, Vandenberghe I, Aussagues Y,
Ausseil F, Lavaud C, Sautel F, Massiot G. J Nat Prod. 2011 Dec 14. PMID : 22168134
Correlating early evolution of parasitic platyhelminths to Gondwana breakup.
Badets M, Whittington I, Lalubin F, Allienne JF, Maspimby JL, Bentz S, Du Preez LH, Barton D, Hasegawa H, Tandon V, Imkongwapang R, Ohler A,
Combes C, Verneau O. Syst Biol. 2011 Dec 1 ;60(6):762-81
[Neoadjuvant treatment of breast cancer : Implications for the pathologist].
Le Guellec S, Perallon R, Alunni JP, Charitansky H, Leaha C, Gonzalez AM, Chateau MC, Simony-Lafontaine J, Jacot W, Gutowski M, Penault-Llorca F,
Dalenc F, Lacroix-Triki M. Ann Pathol. 2011 Dec ;31(6):442-54.
Characteristics of lung cancer in women : Importance of hormonal and growth factors.
Rouquette I, Lauwers-Cances V, Allera C, Brouchet L, Milia J, Nicaise Y, Laurent J, Delisle MB,
Favre G, Didier A, Mazières J. Lung Cancer. 2011 Dec 22. PMID : 22197614
Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO).
Lecarpentier J, Noguès C, Mouret-Fourme E, Stoppa-Lyonnet D, Lasset C, Caron O, Fricker JP,
Gladieff L, Faivre L, Sobol H, Gesta P, Frenay M, Luporsi E, Coupier I ; GENEPSO, Lidereau R, Andrieu N. Breast Cancer Res Treat. 2011 Dec ;130(3):927-38.
Management of gastrointestinal stromal tumours of limited size : Proposals from a French panel of physicians.
Landi B, Bouché O,
Guimbaud R, Aparicio T, Berger A, Bonvalot S, Buecher B, Blay JY, Boustière C, Coindre JM, Emile JF, Giovannini M, Lecomte T, Le Cesne A, Monges G, Napoléon B, Palazzo L, Chayvialle JA. Dig Liver Dis. 2011 Dec ;43(12):935-9.
Apelin Treatment Increases Complete Fatty Acid Oxidation, Mitochondrial Oxidative Capacity, and Biogenesis in Muscle of Insulin-Resistant Mice.
Attané C, Foussal C, Le Gonidec S, Benani A, Daviaud D, Wanecq E, Guzmán-Ruiz R, Dray C, Bezaire V, Rancoule C, Kuba K, Ruiz-Gayo M,
Levade T, Penninger J, Burcelin R, Pénicaud L, Valet P, Castan-Laurell I. Diabetes. 2011 Dec 30. PMID : 22210322
Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants : Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemostasis.
Sié P, Samama CM, Godier A, Rosencher N, Steib A, Llau JV, Van der Linden P, Pernod G, Lecompte T, Gouin-Thibault I, Albaladejo P.
Arch Cardiovasc Dis. 2011 Dec ;104(12):669-76.
Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis : A randomized trial comparing 3- and 6-month periodicities.
Trinchet JC, Chaffaut C, Bourcier V, Degos F, Henrion J, Fontaine H, Roulot D, Mallat A, Hillaire S, Cales P, Ollivier I,
Vinel JP, Mathurin P, Bronowicki JP, Vilgrain V, N’kontchou G, Beaugrand M, Chevret S ; for the Groupe d’Etude et de Traitement du Carcinome Hépatocellulaire (GRETCH). Hepatology. 2011 Dec ;54(6):1987-1997. doi : 10.1002/hep.24545. PMID : 22144108